Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1966 1
1967 2
1968 2
1969 3
1970 2
1971 3
1972 8
1973 5
1974 4
1975 10
1976 16
1977 18
1978 15
1979 11
1980 21
1981 17
1982 17
1983 28
1984 19
1985 18
1986 8
1987 20
1988 14
1989 27
1990 29
1991 16
1992 32
1993 23
1994 23
1995 29
1996 19
1997 28
1998 31
1999 29
2000 40
2001 27
2002 59
2003 56
2004 36
2005 52
2006 61
2007 60
2008 85
2009 86
2010 92
2011 82
2012 105
2013 131
2014 149
2015 166
2016 155
2017 159
2018 190
2019 158
2020 205
2021 200
2022 160
2023 155
2024 79

Text availability

Article attribute

Article type

Publication date

Search Results

2,858 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hypertrophic cardiomyopathy 3"
Page 1
Hypertrophic cardiomyopathy: a review.
Hensley N, Dietrich J, Nyhan D, Mitter N, Yee MS, Brady M. Hensley N, et al. Anesth Analg. 2015 Mar;120(3):554-569. doi: 10.1213/ANE.0000000000000538. Anesth Analg. 2015. PMID: 25695573 Review.
Hypertrophic cardiomyopathy (HCM) is a relatively common disorder that anesthesiologists encounter among patients in the perioperative period. ...Cardiac magnetic resonance imaging also has a diagnostic role by determining the extent and location of left ventricular
Hypertrophic cardiomyopathy (HCM) is a relatively common disorder that anesthesiologists encounter among patients in the perio
Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
Adamczak DM, Oko-Sarnowska Z. Adamczak DM, et al. Cardiol Rev. 2018 May/Jun;26(3):145-151. doi: 10.1097/CRD.0000000000000184. Cardiol Rev. 2018. PMID: 29621050 Review.
Hypertrophic cardiomyopathy (HCM) is a heart disease characterized by hypertrophy of the left ventricular myocardium and is most often caused by mutations in sarcomere genes. ...
Hypertrophic cardiomyopathy (HCM) is a heart disease characterized by hypertrophy of the left ventricular myocardium and is mo
Hypertrophic cardiomyopathy. Proposal for a new classification.
Llamas-Esperón GA, Llamas-Delgado G. Llamas-Esperón GA, et al. Arch Cardiol Mex. 2022;92(3):377-389. doi: 10.24875/ACM.21000301. Arch Cardiol Mex. 2022. PMID: 35772124 Free PMC article. Review.
Hypertrophic cardiomyopathy (HCM) is a clinical condition, but its name has been subjected to frequent changes over the years, largely because of its morphological and functional heterogeneity, which leads the clinician who is focused on its study to have difficulty
Hypertrophic cardiomyopathy (HCM) is a clinical condition, but its name has been subjected to frequent changes over the years,
The Ups and Downs of Genetic Diagnosis of Hypertrophic Cardiomyopathy.
Gómez J, Reguero JR, Coto E. Gómez J, et al. Rev Esp Cardiol (Engl Ed). 2016 Jan;69(1):61-8. doi: 10.1016/j.rec.2015.10.001. Epub 2015 Dec 5. Rev Esp Cardiol (Engl Ed). 2016. PMID: 26654849 Review.
This technology has reduced the effort and cost needed to analyze several genes simultaneously and has made genetic evaluation available to a larger number of patients. In hypertrophic cardiomyopathy, genetic analysis has increased from the 3 main genes impli …
This technology has reduced the effort and cost needed to analyze several genes simultaneously and has made genetic evaluation available to …
Hypertrophic Cardiomyopathy and Pregnancy: A Retrospective Analysis From a Tertiary Care Hospital.
Sikka P, Suri V, Chopra S, Aggarwal N, Saha SC, Bansal R, Vijayvergiya R, Bahl A. Sikka P, et al. Tex Heart Inst J. 2022 Sep 1;49(5):e207427. doi: 10.14503/THIJ-20-7427. Tex Heart Inst J. 2022. PMID: 36223225 Free PMC article. Review.
Pregnancy in women with hypertrophic cardiomyopathy is not well described. In this retrospective study, we analyzed data on pregnant women with hypertrophic cardiomyopathy who were under follow-up care in the cardiology department of a tertiary care ho …
Pregnancy in women with hypertrophic cardiomyopathy is not well described. In this retrospective study, we analyzed data on pr …
Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis.
Wasserstrum Y, Larrañaga-Moreira JM, Martinez-Veira C, Itelman E, Lotan D, Sabbag A, Kuperstein R, Peled Y, Freimark D, Barriales-Villa R, Arad M. Wasserstrum Y, et al. ESC Heart Fail. 2022 Aug;9(4):2301-2312. doi: 10.1002/ehf2.13914. Epub 2022 Apr 30. ESC Heart Fail. 2022. PMID: 35488723 Free PMC article.
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) with reduced ventricular function (HCMr). ...Patients who developed HCMr in the course of the study had similar mortality but a higher rate of …
AIMS: To describe the phenotype, genetics, and events associated with the development of hypertrophic cardiomyopathy (HCM) wit …
Hypertrophic cardiomyopathy part II--anesthetic and surgical considerations.
Varma PK, Raman SP, Neema PK. Varma PK, et al. Ann Card Anaesth. 2014 Jul-Sep;17(3):211-21. doi: 10.4103/0971-9784.135852. Ann Card Anaesth. 2014. PMID: 24994732 Review.
Hypertrophic cardiomyopathy (HCM) poses many unique challenges regarding the conduct of anesthesia and surgery. ...
Hypertrophic cardiomyopathy (HCM) poses many unique challenges regarding the conduct of anesthesia and surgery. ...
The role of echocardiography for diagnosis and prognostic stratification in hypertrophic cardiomyopathy.
Mandeş L, Roşca M, Ciupercă D, Popescu BA. Mandeş L, et al. J Echocardiogr. 2020 Sep;18(3):137-148. doi: 10.1007/s12574-020-00467-9. Epub 2020 Apr 16. J Echocardiogr. 2020. PMID: 32301048 Free PMC article. Review.
Hypertrophic cardiomyopathy (HCM) is the most frequent cardiac disease with genetic substrate, affecting about 0.2-0.5% of the population. ...
Hypertrophic cardiomyopathy (HCM) is the most frequent cardiac disease with genetic substrate, affecting about 0.2-0.5% of the
Complementary Role of Echocardiography and Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy.
Hindieh W, Chan R, Rakowski H. Hindieh W, et al. Curr Cardiol Rep. 2017 Sep;19(9):81. doi: 10.1007/s11886-017-0897-z. Curr Cardiol Rep. 2017. PMID: 28752280 Review.
PURPOSE OF REVIEW: This review discusses the complementary roles of echocardiography and cardiac magnetic resonance in the diagnosis and management of patients with hypertrophic cardiomyopathy (HCM). RECENT FINDINGS: Imaging using novel echocardiographic techniques …
PURPOSE OF REVIEW: This review discusses the complementary roles of echocardiography and cardiac magnetic resonance in the diagnosis and man …
Apical Aneurysms and Mid-Left Ventricular Obstruction in Hypertrophic Cardiomyopathy.
Sherrid MV, Bernard S, Tripathi N, Patel Y, Modi V, Axel L, Talebi S, Ghoshhajra BB, Sanborn DY, Saric M, Adlestein E, Alvarez IC, Xia Y, Swistel DG, Massera D, Fifer MA, Kim B. Sherrid MV, et al. JACC Cardiovasc Imaging. 2023 May;16(5):591-605. doi: 10.1016/j.jcmg.2022.11.013. Epub 2023 Jan 11. JACC Cardiovasc Imaging. 2023. PMID: 36681586 Free article.
BACKGROUND: Apical left ventricular (LV) aneurysms in hypertrophic cardiomyopathy (HCM) are associated with adverse outcomes. ...Patients with aneurysms had 22% greater SAX PM areas compared with those with elevated LV velocities but no aneurysms (median: 3.0 …
BACKGROUND: Apical left ventricular (LV) aneurysms in hypertrophic cardiomyopathy (HCM) are associated with adverse outcomes. …
2,858 results